Additionally, Li et al. [32] showed that MM cell-derived exosomes delivered lncRUNX2-AS1 to MSCs thereby inhibiting the expression of RUNX2 to reduce the osteogenic potential of MSCs. This evidence concerns the gene RUNX2 and Miyoshi myopathy.